Association between gut microbiome and metabolome in mice suffering from acute carbapenem-resistant Escherichia coli infection.

Increasing evidence highlighted the metabolic associations between host and gut microbiota during infection. However, how host–gut microbiota metabolic partnership response to carbapenem-resistant Escherichia coli (CRE) infection has yet to be elucidated. In this study, we subjected the mice to a single intraperitoneal injection of CRE and studied the alterations of the small molecule metabolites derived from host-microbial co-metabolism, as well as the gut microbiome in mice, at 24 h after infection by a two-level strategy. A panel of metabolites in feces and serum, were found to alter significantly in the CRE group, including 26 joint metabolites between them. Meanwhile, the relative abundance of 14 OTUs in Firmicutes (10 OTU), Bacteroidetes (2 OTU), Actinomycetes (1 OTU), and Proteobacteria (1 OTU) were observed to change after infection. Association analyses demonstrated that 9 OTUs including six in the Firmicutes phylum, two in the Bacteroidetes phylum, and one in the Actinomycetes phylum, were associated with the changes of 49 fecal metabolites and 42 serum metabolites. The study of gut microbiota-host metabolic interactions in the early stage of the infection is expected to provide novel diagnostic methods and therapeutic strategies for CRE infection, bring innovative solutions to resolve the current challenge. [Display omitted] • Serum and fecal metabolomic profile were significantly changed in mice suffering from acute CRE infection. • Alterations in the fecal microbiota were associated with the metabolic signatures in response to acute CRE. • Pathogen-gut microbiota-host metabolic interactions provide novel diagnostic and therapeutic strategies for CRE infection. [ABSTRACT FROM AUTHOR]